Thyroid disease in end-stage renal disease

Area of Science:

• Endocrinology
• Nephrology
• Internal Medicine

Background:

• Hypothyroidism is highly prevalent in end-stage renal disease (ESRD) patients.
• Thyroid hormone metabolism and regulation are altered in ESRD.
• Undiagnosed hypothyroidism is common in this population.

Purpose of the Study:

• To review the prevalence and impact of hypothyroidism in ESRD.
• To discuss challenges in interpreting thyroid function tests in CKD.
• To highlight the need for further research on treatment efficacy and safety.

Main Methods:

• Review of epidemiologic data on hypothyroidism prevalence in CKD.
• Analysis of factors affecting thyroid hormone metabolism in ESRD.
• Synthesis of evidence linking thyroid dysfunction to adverse outcomes in CKD.

Main Results:

• Hypothyroidism is nearly five times more prevalent in advanced chronic kidney disease (CKD) patients.
• Thyroid dysfunction is associated with increased cardiovascular risk, worse patient outcomes, and reduced survival in advanced CKD and ESRD.
• Limited data suggests potential benefits of hypothyroidism treatment, but more research is required.

Conclusions:

• High burden of hypothyroidism in ESRD necessitates further investigation.
• Optimal management strategies for thyroid dysfunction in CKD require more robust evidence.
• Clinical trials are needed to evaluate the efficacy and safety of thyroid hormone supplementation.